Oura Inc, the innovative maker of health-tracking smart rings, has decided to delay its highly anticipated initial public offering (IPO) due to “uncertainty” in the current market conditions. The announcement came via a press release on Tuesday, where the company indicated that despite strong interest from investors, the IPO would not proceed at this time.
The IPO landscape started positively in the early part of the year but saw a decline during the third quarter, as reported by research firm Renaissance Capital. Several factors contributed to this downturn, including fears surrounding a potential slowdown in spending within the artificial intelligence sector, recent rate hikes from the Federal Reserve, and a significant increase in bond yields, all of which have made borrowing costs higher.
Oura offers its users a smart ring designed to monitor various health metrics, including sleep quality and physical activity. The company’s revenue primarily comes from ring sales, supplemented by subscription services.
Building momentum leading into its IPO, Oura recently released the Oura Ring 5, which has drawn in 5.7 million paid members. The firm forecasts a remarkable 90% increase in revenue for the fiscal year ending this Wednesday.
Originally, Oura intended to sell 50 million shares at a price range of $40 to $44. At the midpoint of this range, the company’s market valuation would have reached approximately $13.5 billion, with nearly 75% of shares expected to be sold by current stakeholders.
Editor’s Take
The postponement of Oura’s IPO underscores significant challenges in the market, particularly for tech companies reliant on consumer spending. For users, this may signal a delay in the company’s growth and potential new features. For investors and the broader tech sector, it highlights the cautious climate due to macroeconomic factors. The future trajectory of startups in the health tech space may now hinge on how they navigate this landscape.
Source: www.theguardian.com
